abs356.txt	background		self-expandable	metal	stents	are	often	used	for	the	palliativetreatment	of	dysphagia	in	patients	with	advanced	esophageal	cancer	and	ananticipated	limited	survival		due	to	previous	reports	of	a	high	rate	of	adverseevent	when	used	long-term		concerns	have	been	raised	with	regard	to	the	use	ofself-expandable	metal	stents	in	patients	with	a	longer	survival	aim		assess	the	role	of	esophageal	self-expandable	metal	stents	in	patients	withadvanced	esophageal	cancer	that	have	survived	longer	than	six	months	methods		retrospective	study	of	patients	with	advanced	esophageal	cancer	with	aself-expandable	metal	stent	and	a	stent	placement	time	greater	than	six	months	results		forty-two	patients	were	followed	up	for	298	days		there	was	a	clinicalimprovement	in	all	patients		however		59%	of	patients	experienced	an	adverseevent		the	median	stent	patency	was	236	days		endoscopic	management	was	attemptedin	all	self-expandable	metal	related	adverse	events		with	a	clinical	success	rateof	100%		however		the	previously	treated	adverse	event	recurred	in	sevenpatients		multivariate	analysis	showed	that	strictures	that	were	traversable	withan	ultrathin	gastroscope	were	associated	with	a	higher	risk	of	adverse	events	(p=	0	035)	conclusions		long-term	esophageal	stenting	in	patients	with	advanced	esophagealcancer	is	associated	with	a	high	prevalence	of	adverse	events	without	an	impacton	mortality		most	cases	can	be	managed	endoscopically	
